Mirati Therapeutics, Inc.

MORGAN STANLEY

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

6,169,382

Value ($000)

362,451

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	362,451	0.0%	6,169,382	12/31/2023
2023 Q3	11/15/2023	107,250	0.0%	2,462,132	9/30/2023
2023 Q2	8/14/2023	102,771	0.0%	2,844,472	6/30/2023
2023 Q1	5/15/2023	76,273	0.0%	2,051,453	3/31/2023
2022 Q4	2/14/2023	76,561	0.0%	1,689,711	12/31/2022
2022 Q3	11/14/2022	68,943	0.0%	987,155	9/30/2022
2022 Q2	10/27/2022	60,784	0.0%	905,434	6/30/2022
2022 Q1	10/27/2022	10,311	0.0%	125,410	3/31/2022
2021 Q4	2/14/2022	3,915	0.0%	26,692	12/31/2021
2021 Q3	11/15/2021	5,868	0.0%	33,168	9/30/2021
2021 Q2	8/23/2021	12,376	0.0%	76,627	6/30/2021
2021 Q1	5/17/2021	9,185	0.0%	53,618	3/31/2021
2020 Q4	2/16/2021	48,333	0.0%	220,054	12/31/2020
2020 Q3	11/13/2020	5,061	0.0%	30,476	9/30/2020
2020 Q2	8/14/2020	3,060	0.0%	26,801	6/30/2020
2020 Q1	5/26/2020	2,216	0.0%	28,816	3/31/2020
2019 Q4	2/14/2020	18,502	0.0%	143,583	12/31/2019
2014 Q1	5/13/2014	1,054	0.0%	55,315	3/31/2014
2013 Q4	2/13/2014	158	0.0%	9,502	12/31/2013